Randomized Controlled Trial of a Home‐Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor‐Associated Arthralgia in Breast Cancer Survivors

BACKGROUND. In postmenopausal women diagnosed with breast cancer (BC), most BC tumors are hormone receptor positive and guidelines recommend adjuvant endocrine therapy that includes an aromatase inhibitor (AI). This study investigates the impact of a 6‐week, home‐based, self‐directed walking program...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyrop, Kirsten A., Callahan, Leigh F., Cleveland, Rebecca J., Arbeeva, Liubov L., Hackney, Betsy S., Muss, Hyman B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634775/
https://www.ncbi.nlm.nih.gov/pubmed/28698390
http://dx.doi.org/10.1634/theoncologist.2017-0174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634775/
https://www.ncbi.nlm.nih.gov/pubmed/28698390
http://dx.doi.org/10.1634/theoncologist.2017-0174

Ejemplares similares